Article info

Download PDFPDF
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study
  1. Correspondence to Professor Dr Gabriela Riemekasten, C12, CCM, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany; Gabriela.Riemekasten{at}charite.de
View Full Text

Citation

Becker MO, Brückner C, Scherer HU, et al
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study

Publication history

  • Accepted October 3, 2010
  • First published November 10, 2010.
Online issue publication 
May 27, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.